Skip to main content
Clinical Trials/JPRN-UMIN000007427
JPRN-UMIN000007427
Recruiting
未知

A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma. - A prospective co-hort study about efficacy and safety for sorafenib treatment in patients with advanced hepatocellular carcinoma.

Division of Gastroenterology, Department of Medicine Kurume University School of Medicine0 sites300 target enrollmentMarch 2, 2012

Overview

Phase
未知
Intervention
Not specified
Conditions
Hepatocellular carcinoma
Sponsor
Division of Gastroenterology, Department of Medicine Kurume University School of Medicine
Enrollment
300
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 2, 2012
End Date
March 31, 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Division of Gastroenterology, Department of Medicine Kurume University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • An infectious disease of the activity (but except the viral hepatitis) An overlap cancer of the activity A past of sensitivity to iodocontrast media A pregnant woman, a nursing girl may be pregnant The case that the medical attendant judged to be inappropriate as an object of the final examination for reasons of others (problem cases such as a patient does not hear instructions or the support of the family not being provided)

Outcomes

Primary Outcomes

Not specified

Similar Trials